P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
0.1816
+0.0175 (10.65%)
Apr 1, 2025, 3:47 PM EDT - Market open
Company Description
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States.
It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
P3 Health Partners Inc.
Country | United States |
Founded | 2015 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 400 |
CEO | Aric Coffman |
Contact Details
Address: 2370 Corporate Circle, Suite 300 Henderson, Nevada 89074 United States | |
Phone | 702 910 3950 |
Website | p3hp.org |
Stock Details
Ticker Symbol | PIII |
Exchange | NASDAQ |
Stock Type | Common Stock |
Share Class | Class A Shares |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001832511 |
CUSIP Number | 744413105 |
ISIN Number | US7444131053 |
Employer ID | 85-2992794 |
SIC Code | 8000 |
Key Executives
Name | Position |
---|---|
Dr. Aric Coffman M.D. | Chief Executive Officer and President |
Dr. Amir Bacchus M.B.A., M.D. | Co-Founder, Chief Medical Officer and Director |
Leif Pedersen | Chief Financial Officer |
William Bettermann | Executive Vice President and Chief Operating Officer |
Devery Goodey | Senior Vice President of Technology |
Sarah Bussmann B.S.N., CRNI, M.H.A., R.N. | Chief Administrative Officer |
Todd M. Smith | Chief Legal Officer, Chief Compliance Officer and Corporate Secretary |
Kassi Belz APR | Executive Vice President of Communications, Culture and Engagement |
Todd Lefkowitz MHA | Chief Managed Care Officer |
Rebecca Lindy | Executive Vice President of Healthcare Economics |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 1, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
Mar 28, 2025 | 10-K | Annual Report |
Mar 27, 2025 | 8-K | Current Report |
Mar 3, 2025 | DEF 14A | Other definitive proxy statements |
Feb 20, 2025 | PRE 14A | Other preliminary proxy statements |
Feb 18, 2025 | 8-K | Current Report |
Feb 13, 2025 | 8-K | Current Report |
Jan 31, 2025 | SCHEDULE 13D/A | Filing |
Dec 17, 2024 | 8-K | Current Report |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |